Skip to main content
Laurence Corash, MD, Hematology, San Francisco, CA

LaurenceM.CorashMD

Hematology San Francisco, CA

Physician

Dr. Corash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Corash's full profile

Already have an account?

  • Office

    505 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-353-1672
    Fax+1 415-353-1804

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1969 - 1971
  • New York University School of Medicine
    New York University School of MedicineClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis
    Laurence Corash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cerus Corporation Celebrates World Blood Donor Day 2021
    Cerus Corporation Celebrates World Blood Donor Day 2021June 14th, 2021
  • Cerus Corporation Announces Presentation of Study Results with INTERCEPT-Treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting
    Cerus Corporation Announces Presentation of Study Results with INTERCEPT-Treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual MeetingDecember 4th, 2020
  • Cerus Corporation : Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems
    Cerus Corporation : Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood SystemsJuly 30th, 2020
  • Join now to see all